Frequently Asked Questions
The market is segmented based on Global Gastrointestinal/GI Stent Market, By Product (Pancreatic Stents, Biliary Stents, Colonic Stents, Duodenal Stents and Oesophageal Stents), Material (Plastic Stents, Self-Expanding Metal Stents and Covered Self-Expandable Metallic Stents), Type (Anti-Migratory Stents, Drug-Eluting Stents, Radioactive Stents, Anti-Reflux Stents, Shape-Modified Stents and Biodegradable Stents), Disease Type (Gastrointestinal Cancer, Biliary Diseases and Inflammatory Bowel Diseases), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centre and Others) – Industry Trends and Forecast to 2030.
.
The Global Gastrointestinal Gi Stent Market size was valued at USD 482.14 USD Million in 2022.
The Global Gastrointestinal Gi Stent Market is projected to grow at a CAGR of 5.5% during the forecast period of 2023 to 2030.
The major players operating in the market include BD, Boston Scientific Corporation, Medtronic, Terumo Corporation, Johnson & Johnson Services , 3M, Smith & Nephew, Diagmed Healthcare, Medline Industries , Baxter, B. Braun Melsungen AG, Danaher, General Electric Company, CONMED Corporation, Hobbs Medical , Olympus Corporation, Cantel Medical, ConvaTec , M.C. Johnson Company , Merit Medical Systems.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
